Home  >  News
  Prometic receives US FDA orphan drug status for its inter-alpha-inhibitor-proteins for treatment of NEC,   February 17, 2018
  Stallergenes gets approval for Actair for treatment of house dust mite allergy,   February 17, 2018
  ISA grants exclusive license to Scancell to develop and commercialise AMPLIVANT:Modi-1 conjugate therapy,   February 17, 2018
  Janssen's Erleada receives US FDA approval for non-metastatic prostate cancer treatment,   February 16, 2018
  US FDA approves Erleada for treatment of certain type of prostate cancer,   February 16, 2018
  Allecra Therapeutics' lead product candidate AAI101 receives US FDA fast track status,   February 16, 2018
  US FDA to review Amgen sBLA to treat MRD-positive B-cell precursor,   February 16, 2018
  Lilly announces positive top-line phase 3 results for Taltz (ixekizumab) in ankylosing spondylitis,   February 15, 2018
  ImmunoQure, Servier enter into strategic partnership for the development of an interferon-alpha human autoantibody,   February 15, 2018
  Pain Therapeutics resubmits NDA with US FDA for REMOXY ER,   February 15, 2018
  Catalyst Pharmaceuticals announces plans to resubmit new drug application for Firdapse,   February 14, 2018
  Icon Bioscience receives FDA approval for dexycu, a potentially transformational drug therapy for treating inflammation associated with cataract surgery,   February 14, 2018
  AVEO announces EUSA Pharma granted positive NICE recommendation for fotivda,   February 14, 2018
  Opiant Pharmaceuticals announces development of OPNT003 for treatment of opioid overdose,   February 14, 2018
  Novartis's Sandoz receives US FDA approval for Glatopa,   February 14, 2018
  Advanced Accelerator applications enters into worldwide license agreement with cancer targeted technology,   February 13, 2018
  Santen presents phase I/II data on DE-122 (Carotuximab) in patients with refractory wet age-related macular degeneration,   February 13, 2018
  Seattle Genetics, Pieris Pharmaceuticals announce multi-programme immuno-oncology collaboration,   February 13, 2018
  US FDA approves Zytiga in combo with prednisone to treat patients with metastatic high-risk castration-sensitive prostate cancer,   February 10, 2018
  Sanofi begins tender offer for acquisition of Bioverativ,   February 10, 2018

Pharmabiz: PPM_150x60_2018
Copyright © 2016 Saffron Media Pvt. Ltd |